Samantha Williams, a mother, is lending her support to The Mirror’s initiative advocating for the inclusion of NHS heel prick tests for Spinal Muscular Atrophy (SMA) in the NHS services without reservation. Her son, Lucian Neale, now two-and-a-half years old, was diagnosed with SMA Type 1 when he was just seven weeks old, a condition that typically has a life expectancy of two years without treatment.
Following the diagnosis, Samantha, 38, and her partner Justin Neale, 39, were advised to prepare for the worst and initiate palliative care. Against the odds, Lucian survived and has achieved significant milestones such as sitting up unaided, standing with leg splints, propelling his wheelchair, speaking a few words, and is preparing to start nursery school in September.
Reflecting on their journey, Samantha emphasizes the critical importance of early detection through a simple heel prick test administered at birth. She firmly believes that if Lucian had undergone this test, the outcome would have been vastly different, significantly improving his quality of life. Samantha, who works at a supermarket and resides in Sofrydd, Newport, South Wales, stresses that the heel prick test, costing only £5 for the NHS, could have been transformative for them and Lucian.
Expressing her full support for The Mirror’s campaign, Samantha underscores the urgency of diagnosing SMA early in infants and children to mitigate the severity of symptoms. She highlights the crucial role of timely diagnosis in initiating prompt treatment, which not only saves lives but also arrests muscle degeneration effectively.
Samantha draws attention to the painful reality faced by parents when their child’s condition is diagnosed late, often leading to irreversible consequences. She firmly believes that if Lucian had undergone the heel prick test, he would be leading a normal life today. Samantha’s endorsement of the campaign comes in the wake of pop star Jesy Nelson’s revelation about her twins, Ocean and Story, being diagnosed with SMA Type 1, underscoring the urgent need for awareness and action.
The journey of Samantha and Lucian began in October 2022, shortly after the loss of another baby, Carson, at 30 weeks. Lucian was born via C-section at 37 weeks, following complications including low movement and gestational diabetes. Samantha recalls the early signs of concern, including Lucian’s unusual breathing patterns and cessation of movements, prompting her to research SMA online, leading to his hospitalization and subsequent diagnosis.
Following the diagnosis of SMA Type 1 at seven weeks, Samantha and Justin explored alternative treatment options, ultimately opting for Risdiplam, an oral drug that aids in SNM protein production. Lucian’s gradual improvement on this treatment regimen offered a glimmer of hope, leading to his discharge from the hospital after a month-long stay. Subsequent gene therapy in October 2023 marked a turning point in Lucian’s journey, enabling him to achieve significant developmental milestones despite the challenges posed by SMA.
Samantha’s story serves as a beacon of hope for families grappling with similar challenges, emphasizing the importance of early intervention and access to innovative treatments. Her unwavering advocacy for the heel prick test and continued support for SMA awareness initiatives underscore the resilience and determination of parents facing life-altering circumstances.